The online CME search engine.

Contemporary Management of Pemphigus Vulgaris: The Role of the Rheumatologist

Provided by:

Course Description

Pemphigus vulgaris (PV) is a rare autoimmune mucocutaneous blistering disease associated with significant morbidity when not treated promptly. While most patients are initially treated with glucocorticoids and adjuvant immunosuppressive agents by a dermatologist, some patients are nonresponsive. This interactive web monograph provides an overview of PV and its diagnosis and current treatment as well as data on the safety and efficacy of emerging therapies such as rituximab, dapsone, and methotrexate. Because most dermatologists do not provide infusion therapies, they often confer with rheumatologists, who are better equipped to screen patients for suitability for intravenous infusion of biologics such as rituximab. Rheumatologists therefore need to be aware of their potential role in managing these patients in concert with dermatologists.

Ratings and Reviews

To review this course, please login.

Please Review This Course

Overall Quality

Instructor

Usefulness

150 Characters Minimum

Submit
Course Information

Overall Quality

(0)

Instructor

(0)

Usefulness

(0)
Add to Transcript Write Review

Learning Format 1 Hours
Self-Study

Credit Type(s)
Dermatology Rheumatology